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Ischemic stroke is a dangerous medical
condition that occurs when blood supply to
brain tissues is lost. This usually happens as
a result of substantial blood pressure drops,
or when blood vessels are blocked by clots.
In either case, affected tissues can die, often
leading to permanent impairment of men-
tal and physical faculties, the shutdown of
essential bodily functions, or even death.
If tissue death could be prevented until
the blood supply is restored, then stroke
prognosiscould beimproved. However,the
mechanisms underlying this damage are
still poorly understood, and so far only one
effective treatment exists. This treatment,
a blood-thinning medication intended
to disintegrate blood clots, can’t be used
in most patients without risk of serious
complications. This lack of effective treat-
ments for stroke is becoming ever more
urgent as the generation born in the baby
boom after WWII are now reaching an age
where stroke is of particular concern.
Fortunately, a new ray of hope is offered
in this issue of PLoS Biology, where a group
of researchers representing ten institutions
and four countries describe a new potential
therapeutic target for acute stroke.
Headed by Christoph Kleinschnitz (Ger-
many) and Harald Schmidt (The Nether-
lands), the group set its sights on the
potential for oxidative stress to cause tissue
damage after stroke. On a cellular level,
oxidative stress occurs when reactive oxy-
gen species (ROS) accumulate within the
cell. ROS are normally an important part
of cellular physiology, occurring as bypro-
ducts of metabolic reactions, or participat-
ing in signaling pathways. However, be-
cause they are very chemically reactive,
they can easily damage DNA, lipids, and
proteins when present in high amounts.
Although oxidative stress has long been
suspected to play a role in tissue damage
after stroke, no study has ever clearly
demonstrated a link between the two.
Moreover, earlier efforts to prevent ROS-
mediated tissue damage by administering
antioxidants (which soak up loose ROS)
after stroke did not improve therapeutic
outcome. Nonetheless, Kleinschnitz and
colleagues wondered whether a better
outcome might be obtained by blocking
ROS production at its source, rather than
trying to clean up excess ROS after the
fact. This seemed a daunting task because
there are many potential ROS sources in
the body and brain, but fortunately, a
promising lead developed, pointing them
toward a gene called NOX4.
Previous studies had shown that NOX4
is a member of a family of proteins that
produce ROS in mice. It is found in the
cells that line blood vessels throughout the
body, but is particularly concentrated in
the blood vessels of the brain and in
neurons. Additionally, NOX4’s expression
had been shown to increase when stroke is
induced in rats. Kleinschnitz et al. there-
fore set out to determine how NOX4
contributes to stroke outcome. To do this,
they engineered NOX4-deficient mice and
explored how these mice cope with stroke.
Strikingly, the group found that NOX4-
deficient mice exhibited a smaller extent of
tissue death, experienced less severe neuro-
logical deficits, and survived for longer after
stroke than did wild-type mice. Further-
more, while elevated ROS levels, ROS-
damaged proteins, and neuronal cellular
suicide were quite evident in the brains of
post-stroke wild-type mice, NOX4-deficient
micedisplayedmuchlowerlevelsofallthese
indicators. NOX4deficiencyalsocorrelated
with reduced fluid flooding in brain regions
adjacent to the stroke, which the authors
suggest could be related to decreased
damageand leakiness of brainblood vessels.
Importantly, protective effects of
NOX4-deficiency are evident in adult
mice of both sexes, and also in elderly
mice. And, these effects are specific to
NOX4 because deficiency in other NOX
family members (that are not expressed in
the brain) had no effect on the animals’
stroke resiliency. These details indicate
both the strong specificity and universality
of NOX4 deficiency in protecting against
stroke-mediated brain damage.
What implications does this work have
for therapeutic approaches to stroke? From
the perspective of those designing thera-
peutic interventions, it’s encouraging that
NOX4-deficient animals appear to do just
fine without NOX4; they do not show any
signs of dysfunction in other areas where
NOX4 is normally expressed (e.g., periph-
eral blood vessels that serve the kidneys and
heart). What’s more, Kleinschnitz and
colleagues showed that a chemical inhibitor
of NOX activity significantly improves
post-stroke outcomes in wild-type mice
when administered within two hours of
stroke onset. A more specific NOX4
inhibitor might therefore turn out to be a
useful drug in clinical settings in humans.
Future studies will be needed to explore the
full potential of these findings.
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Ischemic infarcts (TTC staining) of brain
sections from wild-type mice (left) and
mice in which the NOX4 gene has been
knocked out (right) 24 hours after a
transient occlusion of middle cerebral
artery, a model of stroke. Ischemic
infarcts (white areas indicating brain
damage) are substantially smaller in
NOX4 knockout mice and are associated
with improved neuronal functions and
survival. Image: Christoph Kleinschnitz.
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